Not All Exosomes Are Yours:
Understanding Autologous Exosome Therapy
Treatments sold under the word "exosomes" can be profoundly different from one another — starting with the most fundamental question of all: whose exosomes are they?
Trichoscopic assessment at Hortman Clinic, Jumeirah — the examination that determines whether autologous exosome therapy is indicated, and where on the scalp it should be targeted.
If you have been researching regenerative treatments for hair thinning, you have almost certainly come across the word "exosomes." It appears everywhere — in clinic menus, on social media, in serum marketing. What almost no one explains is that treatments sold under this single word can be profoundly different from one another, starting with the most fundamental question of all: whose exosomes are they?
This article explains what exosomes actually are, why their origin matters, and how a new generation of in-clinic technology now makes it possible to use your own — concentrated from your own blood, in a single visit.
1What exosomes actually are
Exosomes are microscopic vesicles — between 30 and 150 nanometres across — released by cells as a communication system. Think of them as sealed envelopes carrying biological instructions: proteins, lipids and genetic messengers (such as microRNAs) that tell neighbouring cells how to behave.
In the context of the scalp, this signalling is of particular interest because the hair follicle is an organ in constant dialogue with its environment, cycling between growth, transition and rest. Exosomes are not a drug and not a synthetic invention. They are something your body produces continuously. The therapeutic question has always been how to gather enough of them, from the right source, in a usable form.
Exosomes are microscopic biological envelopes — 30 to 150 nanometres across — carrying the signalling instructions that tell neighbouring cells how to behave.
2The question no one asks: where do the exosomes come from?
This is where the market becomes confusing — and where an informed patient should slow down. Broadly, three categories of "exosome treatment" exist today. Understanding the differences between them is the most important thing you can know before booking anything.
Extracted from botanical sources, these are common in cosmetic serums and some topical clinic treatments. They are not human exosomes. Plant vesicles carry plant signalling content, and whether they communicate meaningfully with human follicular cells remains an open scientific question. They are inexpensive to produce — which explains their popularity — but biologically, they are the most distant option from your own physiology.
Produced in laboratory conditions from cultured human cells — for example, adipose-derived stem cells — and standardised batch to batch under pharmaceutical-grade manufacturing. These are the scientifically serious allogeneic option: rigorously characterised, consistent, and produced under GMP conditions. Their defining feature is standardisation — every vial is the same. Read more about ADSC-derived exosome therapy.
The newest category, and the subject of this article: exosomes concentrated directly from your own blood, in clinic, during your appointment. No donor. No culture. No question of biological compatibility — because the material is entirely yours.
3The problem with your own exosomes — until now
If autologous is so appealing, why has it not been standard practice? The honest answer: your exosomes were being thrown away.
Platelet-rich plasma (PRP) has been used in hair clinics for years. To prepare it, blood is centrifuged and separated into layers, and the platelet-rich fraction is kept for injection. But exosomes are so small that they do not sediment with the platelets — most remain dispersed in the so-called platelet-poor plasma, the fraction that standard PRP protocols discard.
In other words: conventional PRP preparation has been quietly disposing of one of the most biologically interesting components of your own blood.
Standard PRP preparation retains the platelet-rich fraction — and discards the platelet-poor plasma where most of your exosomes remain.
Want to know if autologous exosome therapy is appropriate for your scalp? Trichoscopic assessment gives us the evidence to recommend the right protocol — or to rule it out.
4How autologous exosome concentration works
Exosmart™ is a CE-certified Class IIa medical device, manufactured in Italy under ISO 13485, designed to solve exactly this problem through closed-system ultrafiltration. The entire in-clinic process takes approximately 30 minutes. Nothing is added, cultured or stored. It is your biology, refined.
5Why "complete secretome" matters
A detail worth understanding: this preparation is deliberately not a purified exosome isolate. Tissue repair in the body is a coordinated effort — exosomes signal, platelets release growth factors, plasma proteins provide structural support. Concentrating the full spectrum together preserves that natural teamwork rather than isolating a single actor from it.
The concentrated preparation is applied immediately via fine intradermal microinjections — targeted to the areas identified during trichoscopic assessment.
6An honest word about evidence
Regenerative medicine is a field where enthusiasm often outruns data, and we believe patients deserve candour. The performance figures published for point-of-care exosome devices — including this one — originate largely from manufacturer studies rather than large independent peer-reviewed trials. The device's certification, engineering and safety profile are well documented; the clinical evidence base in hair applications is still maturing, as it is across the entire exosome category.
This is precisely why, in our practice, no regenerative treatment is ever prescribed from a menu. It is selected — or ruled out — on the basis of instrumental diagnosis, and its effect is monitored objectively over time.
7It starts under the trichoscope
Before any discussion of exosomes, platelets or protocols, there is a more fundamental question: what is actually happening at your follicles? Trichoscopy — magnified, structured examination of the scalp and hair shafts — answers that question with evidence rather than assumption. It establishes whether a regenerative protocol is appropriate for you at all, where on the scalp it should be targeted, and provides the baseline against which progress is measured at every follow-up.
Autologous exosome therapy is a remarkable tool. But a tool is only as good as the diagnosis that guides it.
Frequently Asked Questions
The preparation is made entirely from your own blood within a closed, CE-certified system — which removes the compatibility considerations associated with donor-derived or plant-derived material. As with any injectable procedure, individual suitability is determined at your clinical assessment.
PRP keeps the platelet-rich fraction of your plasma and discards the rest. Autologous exosome concentration processes the full plasma volume, retaining and concentrating the exosome-rich fraction that PRP loses — alongside the platelets and growth factors.
This is personalised to your diagnosis and reviewed at each trichoscopic follow-up. There is no universal number, and we would be cautious of any clinic that promises one before examining your scalp.
Suitability is always determined by clinical assessment. Certain medical conditions and medications can affect whether a blood-derived regenerative protocol is appropriate — which is one of several reasons the diagnostic consultation always comes first.
Stem-cell-derived exosomes (such as ASCEplus HRLV) are produced from donor adipose stem cells in a laboratory, standardised under pharmaceutical conditions — consistent, rigorously characterised, and available in known quantities. Autologous exosomes come entirely from your own blood, concentrated in clinic during your appointment. The two approaches are biologically distinct and appropriate for different clinical situations — which is why the diagnostic consultation determines which is indicated for you. Compare all autologous approaches here.
Exosmart™ is a CE-certified Class IIa medical device manufactured in Italy under ISO 13485, designed for closed-system ultrafiltration of autologous plasma in a clinical setting. The full in-clinic process takes approximately 30 minutes from blood draw to application.
This article is for general information only and does not replace a personal clinical consultation. All regenerative treatments are subject to individual suitability assessment. Regulatory status of devices in the UAE should be confirmed with the treating clinic before booking.
A tool is only as good as
the diagnosis that guides it.
If you are experiencing hair thinning or reduced density and want to understand — with evidence — whether autologous exosome therapy has a place in your protocol, begin with a trichoscopic diagnosis at Hortman Clinic, Jumeirah, Dubai.